Purpose: Non-steroidal anti-inflammatory drugs (NSAIDs) are one of the most
commonly used drugs in healing musculoskeletal injuries in sports medicine.
However, this approach is controversial because NSAIDs inhibit the inflammatory
response, which is necessary for proper tissue healing. The purpose of this article
was to present the current state of knowledge on the effects of NSAIDs on soft
tissue and bone healing and to assess whether there are grounds for changing
clinical management in sports medicine. Methods: A systematic search of
MEDLINE (PubMed and Ovid) identified 35 relevant publications, including
clinical trials, preclinical studies, systematic reviews, and meta-analyses. We
analyzed the studies assessing the impact of NSAIDs on soft tissue and bone
healing qualitatively with attention to clinical significance. Results: Animal studies
indicate the adverse effects of some NSAIDs on bone healing, especially
indomethacin and celecoxib. Deteriorated healing results were observed in soft
tissues, especially after rotator cuff reconstruction, following the use of celecoxib.
Non-selective NSAIDs, such as ibuprofen, showed a neutral or beneficial effect in
most studies. However, clinical data remain limited and inconsistent, with some
meta-analyses showing a relationship with patient age while others show no
significant differences. Conclusions: Some NSAIDs, especially selective COX-2
inhibitors, may slow down the healing of soft tissue, and indomethacin may also
slow down the healing of bones. Because there are no clear, high-quality clinical
trials, medical professionals should be careful when giving NSAIDs and only give
the lowest dose for the shortest amount of time that works.
Keywords: non-steroidal anti-inflammatory drugs (NSAID); cyclooxygenase (COX);
bone healing; soft tissue healing; sports medicine